lobbying_activities: 2790984
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2790984 | 53ee718c-546b-4ae8-b995-ffda6fbb1ec3 | Q1 | MEHLMAN CONSULTING, INC. | 284950 | WEDGEWOOD PHARMACY LLC | 2022 | first_quarter | ANI | Issues related to animal drug compounding. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2022-04-20T09:45:24-04:00 |